Cargando…
Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261126/ https://www.ncbi.nlm.nih.gov/pubmed/31782777 http://dx.doi.org/10.1093/brain/awz368 |
| _version_ | 1783540450328576000 |
|---|---|
| author | Pijpers, Judith A Ferrari, Michel D Terwindt, Gisela M |
| author_facet | Pijpers, Judith A Ferrari, Michel D Terwindt, Gisela M |
| author_sort | Pijpers, Judith A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7261126 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72611262020-06-03 Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine Pijpers, Judith A Ferrari, Michel D Terwindt, Gisela M Brain Letters to the Editor Oxford University Press 2020-01 2019-11-29 /pmc/articles/PMC7261126/ /pubmed/31782777 http://dx.doi.org/10.1093/brain/awz368 Text en © The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letters to the Editor Pijpers, Judith A Ferrari, Michel D Terwindt, Gisela M Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine |
| title | Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine |
| title_full | Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine |
| title_fullStr | Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine |
| title_full_unstemmed | Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine |
| title_short | Reply: OnabotulinumtoxinA should be considered in medication overuse withdrawal in patients with chronic migraine |
| title_sort | reply: onabotulinumtoxina should be considered in medication overuse withdrawal in patients with chronic migraine |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261126/ https://www.ncbi.nlm.nih.gov/pubmed/31782777 http://dx.doi.org/10.1093/brain/awz368 |
| work_keys_str_mv | AT pijpersjuditha replyonabotulinumtoxinashouldbeconsideredinmedicationoverusewithdrawalinpatientswithchronicmigraine AT ferrarimicheld replyonabotulinumtoxinashouldbeconsideredinmedicationoverusewithdrawalinpatientswithchronicmigraine AT terwindtgiselam replyonabotulinumtoxinashouldbeconsideredinmedicationoverusewithdrawalinpatientswithchronicmigraine |